Welcome to our dedicated page for Art Technology Acquisition Cor news (Ticker: ARTC), a resource for investors and traders seeking the latest updates and insights on Art Technology Acquisition Cor stock.
Art Technology Acquisition Corp. is a blank-check company, or SPAC, whose news centers on shareholder voting matters, governance actions, capital-structure updates, and security-structure disclosures. ARTC developments are tied to the issuer's SPAC framework, including shareholder approvals, redemption mechanics, deadline extensions, and corporate actions that affect the structure and status of the public vehicle.
Art Technology Acquisition Corp (NASDAQ:ARTCU / ARTC) priced an initial public offering of 22,000,000 units at $10.00 per unit for gross proceeds of $220,000,000. Units begin trading on January 6, 2026 on Nasdaq Global Market under ARTCU; separate Class A shares and warrants are expected to list as ARTC and ARTCW once separated. Each unit includes one Class A share and one-fourth of a redeemable warrant exercisable at $11.50. Closing is expected on or about January 7, 2026, and the underwriter has a 45-day option to purchase up to 3,300,000 additional units.
The company is a blank-check vehicle focused on targets in technology, art, financial services, and investment banking; Clear Street is sole book-running manager.
AdaptHealth Corp. (NASDAQ: AHCO) has announced the appointment of Greg Belinfanti to its Board of Directors, representing One Equity Partners. Belinfanti brings extensive board experience, having served on various healthcare-related boards, including Arthrocare (NASDAQ: ARTC). Brad Coppens, the previous OEP designee, will remain an independent director. Chairman Richard Barasch expressed appreciation for OEP's support and welcomed Belinfanti's expertise, which aims to strengthen the board's leadership and strategic direction.